167 related articles for article (PubMed ID: 21603803)
21. Nevus-associated melanomas: clinicopathologic features.
Shitara D; Nascimento MM; Puig S; Yamada S; Enokihara MM; Michalany N; Bagatin E
Am J Clin Pathol; 2014 Oct; 142(4):485-91. PubMed ID: 25239415
[TBL] [Abstract][Full Text] [Related]
22. A retrospective histological study of 669 cases of primary cutaneous malignant melanoma in clinical stage I. The consequences of a reclassification of the original group of lentigo maligna melanomas.
Larsen TE; Grude TH
Acta Pathol Microbiol Scand A; 1979 Jul; 87A(4):255-60. PubMed ID: 474127
[TBL] [Abstract][Full Text] [Related]
23. The impact of factors beyond Breslow depth on predicting sentinel lymph node positivity in melanoma.
Paek SC; Griffith KA; Johnson TM; Sondak VK; Wong SL; Chang AE; Cimmino VM; Lowe L; Bradford CR; Rees RS; Sabel MS
Cancer; 2007 Jan; 109(1):100-8. PubMed ID: 17146784
[TBL] [Abstract][Full Text] [Related]
24. Presence of histological regression as a prognostic factor in cutaneous melanoma patients.
Tas F; Erturk K
Melanoma Res; 2016 Oct; 26(5):492-6. PubMed ID: 27380112
[TBL] [Abstract][Full Text] [Related]
25. [Evaluation of the epidemiological profile and the mortality rate of the patients with primary cutaneous melanoma in Florianopolis - SC, Brazil].
Battisti R; Nunes DH; Weber AL; Schweitzer LC; Sgrott I
An Bras Dermatol; 2009; 84(4):335-42. PubMed ID: 19851664
[TBL] [Abstract][Full Text] [Related]
26. An update on cutaneous melanoma in Turkey: evaluation of 19-year data in a single tertiary centre and review of the literature.
Baykal C; Atci T; Polat Ekinci A; Buyukbabani N
J Eur Acad Dermatol Venereol; 2017 Feb; 31(2):236-240. PubMed ID: 27519285
[TBL] [Abstract][Full Text] [Related]
27. Comparison between lentigo maligna melanoma and other histogenetic types of malignant melanoma of the head and neck. Scottish Melanoma Group.
Cox NH; Aitchison TC; Sirel JM; MacKie RM
Br J Cancer; 1996 Apr; 73(7):940-4. PubMed ID: 8611411
[TBL] [Abstract][Full Text] [Related]
28. Histopathological Characteristics of Cutaneous Melanoma in Isfahan, Iran, from 2013 to 2018.
Malakoutikhah Z; Mohaghegh F; Karimi S; Rajabi P; Tabatabaei ET
J Skin Cancer; 2022; 2022():4490648. PubMed ID: 36171992
[TBL] [Abstract][Full Text] [Related]
29. Opportunistic screening strategy for cutaneous melanoma does not change the incidence of nodular and thick lesions nor reduce mortality: a population-based descriptive study in the European region with the highest incidence.
Bordoni A; Leoni-Parvex S; Peverelli S; Mazzola P; Mazzucchelli L; Spitale A
Melanoma Res; 2013 Oct; 23(5):402-7. PubMed ID: 23839077
[TBL] [Abstract][Full Text] [Related]
30. [Cutaneous malignant melanoma in Rio Grande do Sul, Brazil: study of 101 cases].
Venegas LF; Flores C; Blacher GG; Daudt AW; Cerski CT
Rev Assoc Med Bras (1992); 1992; 38(3):122-6. PubMed ID: 1340361
[TBL] [Abstract][Full Text] [Related]
31. Epidemiological and histopathological aspects of primary cutaneous melanoma in residents of Joinville, 2003-2014.
Steglich RB; Coelho KMPA; Cardoso S; Gaertner MHDCN; Cestari TF; Franco SC
An Bras Dermatol; 2018; 93(1):45-53. PubMed ID: 29641696
[TBL] [Abstract][Full Text] [Related]
32. Clinicopathological Study of Malignant Melanoma at Tertiary Care Centre.
Thapa S; Ghosh A; Ghartimagar D; Prasad T; Narasimhan R; Talwar O
JNMA J Nepal Med Assoc; 2017; 56(205):132-136. PubMed ID: 28598449
[TBL] [Abstract][Full Text] [Related]
33. Clinicopathologic features and behavior of cutaneous eyelid melanoma.
Vaziri M; Buffam FV; Martinka M; Oryschak A; Dhaliwal H; White VA
Ophthalmology; 2002 May; 109(5):901-8. PubMed ID: 11986095
[TBL] [Abstract][Full Text] [Related]
34. Cutaneous melanoma: a 30-year-long epidemiological study conducted in a city in southern Brazil, from 1980-2009.
Naser N
An Bras Dermatol; 2011; 86(5):932-41. PubMed ID: 22147033
[TBL] [Abstract][Full Text] [Related]
35. A retrospective comparison between preoperative and postoperative Breslow depth in primary cutaneous melanoma: how preoperative shave biopsies affect surgical management.
Saco M; Thigpen J
J Drugs Dermatol; 2014 May; 13(5):531-6. PubMed ID: 24809875
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of melanoma features and their relationship with nodal disease: the importance of the pathological report.
Bertolli E; de Macedo MP; Pinto CA; Damascena AS; Molina AS; Ueno PS; Duprat Neto JP
Tumori; 2015; 101(5):501-5. PubMed ID: 25983100
[TBL] [Abstract][Full Text] [Related]
37. Clinicopathologic findings and BRAF mutation in cutaneous melanoma in young adults.
Estrozi B; Machado J; Rodriguez R; Bacchi CE
Appl Immunohistochem Mol Morphol; 2014 Jan; 22(1):57-64. PubMed ID: 24471189
[TBL] [Abstract][Full Text] [Related]
38. The age-specific effect modification of male sex for ulcerated cutaneous melanoma.
Richardson BS; Anderson WF; Barnholtz-Sloan JS; Tucker MA; Gerstenblith MR
JAMA Dermatol; 2014 May; 150(5):522-5. PubMed ID: 24599332
[TBL] [Abstract][Full Text] [Related]
39. Prognostic factors and epidemiological characteristics of cutaneous and mucosal head and neck melanoma.
Berzina A; Azarjana K; Cema I; Pjanova D; Rivosh A
Stomatologija; 2011; 13(2):49-54. PubMed ID: 21822045
[TBL] [Abstract][Full Text] [Related]
40. Predicting five-year outcome for patients with cutaneous melanoma in a population-based study.
Barnhill RL; Fine JA; Roush GC; Berwick M
Cancer; 1996 Aug; 78(3):427-32. PubMed ID: 8697387
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
